Biomarkers in Acute Myeloid Leukemia: Leveraging Next Generation Sequencing Data for Optimal Therapeutic Strategies

Next generation sequencing (NGS) is routinely used for mutation profiling of acute myeloid leukemia. The extensive application of NGS in hematologic malignancies, and its significant association with the outcomes in multiple large cohorts constituted a proof of concept that AML phenotype is driven b...

Descripción completa

Detalles Bibliográficos
Autores principales: El Achi, Hanadi, Kanagal-Shamanna, Rashmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514876/
https://www.ncbi.nlm.nih.gov/pubmed/34660311
http://dx.doi.org/10.3389/fonc.2021.748250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514876/
https://www.ncbi.nlm.nih.gov/pubmed/34660311
http://dx.doi.org/10.3389/fonc.2021.748250

Ejemplares similares